Showing results (2661-2670 of 2,696) with videos related to
Sort By:
Pageof 270
The Lancet. Infectious Diseases|July 29, 2023
Frequent screening for asymptomatic chlamydia and gonorrhoea infections in men who have sex with men: time to re-evaluate?Eloise Williams, Deborah A Williamson, Jane S HockingThe Lancet. Infectious Diseases|May 11, 2024
Urgent considerations for booster vaccination strategies against Ebola virus diseaseWim Adriaensen, Selien Oostvogels, Yves Levy, et al.The Lancet. Infectious Diseases|May 11, 2024
Field evaluation of validity and feasibility of Pan-Lassa rapid diagnostic test for Lassa fever in Abakaliki, Nigeria: a prospective diagnostic accuracy studyJelte Elsinga, Temmy Sunyoto, Letizia di Stefano, et al.The Lancet. Infectious Diseases|April 28, 2024
Efficacy and immunogenicity following dengue virus-1 human challenge after a tetravalent prime-boost dengue vaccine regimen: an open-label, phase 1 trialKirsten E Lyke, Joel V Chua, Michael Koren, et al.The Lancet. Infectious Diseases|October 14, 2023
Overcoming publication and dissemination bias in infectious diseases clinical trialsMartin P Grobusch, Claire Ruiz Del Portal Luyten, Benjamin J Visser, et al.The Lancet. Infectious Diseases|April 3, 2026
Intravenous immunoglobulin treatment for long COVID: a case report of clinical and immunological findingsMarta Camici, Eva Piano Mortari, Giulia Del Duca, et al.The Lancet. Infectious Diseases|April 20, 2026
Measuring population immunity against influenza using individual antibody titres: a multicountry, retrospective observational studyWeijia Xiong, Xiaotong Huang, Tran Thi Nhu Thao, et al.The Lancet. Infectious Diseases|May 9, 2026
Immunogenicity, reactogenicity, and safety of a reduced-interval 4CMenB primary immunisation schedule in UK infants: a multicentre, open-label, assessor-blinded, phase 4 randomised controlled trialNatasha Thorn, Zsofia Danos, Nick J Andrews, et al.The Lancet. Infectious Diseases|July 15, 2022
Association between women's authorship and women's editorship in infectious diseases journals: a cross-sectional studyKatharina Last, Lilith Hübsch, Muge Cevik, et al.Pageof 270